Pancreatic Cancer Research

ResearcherYokohama City UniversityNo recent work listed

Takeharu Yamanaka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1790-7069; OpenAlex author ID A5003648443. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPA-Enriched Oral Supplement in Advanced Pancreatic Cancer. Last author DOI 10.1080/01635581.2020.1871495↗
  2. Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer. Co-author DOI 10.1245/s10434-017-5799-1↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shinichi Ohkawa · 1 shared paper, 2022 · strength 0.16
  2. Takashi Kaneko · 1 shared paper, 2022 · strength 0.16
  3. Satoshi Kobayashi · 1 shared paper, 2022 · strength 0.16
  4. Manabu Morimoto · 1 shared paper, 2022 · strength 0.16
  5. Makoto Ueno · 1 shared paper, 2022 · strength 0.16
  6. Akira Chikamoto · 1 shared paper, 2017 · strength 0.06
  7. Daisuke Hashimoto · 1 shared paper, 2017 · strength 0.06
  8. Hiroshi Takamori · 1 shared paper, 2017 · strength 0.06
  9. Yasuyuki Yamashita · 1 shared paper, 2017 · strength 0.06
  10. Hideo Baba · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.